Budget 2026 ka Market Reaction
Kal, February 1, 2026 ko Budget announcement ke baad, Indian equity markets mein ekdum se sell-off aa gaya. Sensex aur Nifty dono hi 2% tak neeche aa gaye. Budget mein fiscal prudence aur capital expenditure par focus tha, lekin STT hike ne investors ko thoda pareshan kar diya hai.
STT Hike Ka Drama!
Sabse bada reason F&O (Futures & Options) par STT ka badhna hai. Ab futures par STT 0.02% se badha kar 0.05% ho gaya hai, aur options par 0.10% se 0.15% ho gaya hai. Experts keh rahe hain ki isse domestic brokerages par asar padega aur foreign institutional investors (FIIs) bhi shayad thoda hesitate karein. Government ne yeh step speculation kam karne aur revenue badhane ke liye uthaya hai.
Axis Mutual Fund ke Ashish Gupta ne budget ko "mixed bag" kaha, ki tax regime stable hai par STT increase se disappointment hai. Aditya Birla Sun Life AMC ke Harish Krishnan ne budget ko realistic aur fiscally prudent bataya.
Kahan Hai Mauka? Analysts Ke Top Picks
Market jab giri hui thi, tab bhi analysts ne kuch aise stocks dhundh nikale hain jo budget allocations se fayda utha sakte hain. Infrastructure, AI, digital services aur manufacturing sectors par budget ka focus hai.
- Apollo Hospitals Enterprises: Regional medical tourism aur Biopharma Shakti mission se fayda mil sakta hai. Current Price: ₹6,948.
- Mahindra & Mahindra: ₹1 lakh crore wale infrastructure capex aur farm mechanization se gain kar sakta hai. Current Price: ₹3,364.
- Biocon: Biopharma Shakti mission ka fayda milega, especially diabetes aur oncology mein. Target: ₹460.
- Larsen & Toubro: Infrastructure projects jaise railways aur roads mein capex boost se fayda hoga. Current Price: ₹3,814.
- Indian Hotels Company: Hospitality sector mein achi demand-supply se fayda hoga. Current Price: ₹664.
- Tata Consultancy Services (TCS): AI aur bade deals par focus, plus foreign cloud service providers ke liye tax holiday. Current Price: ₹3,187.
- Sai Life Sciences: Biopharma SHAKTI proposals aur CRDMO market growth se fayda.
- Syrma SGS Technology: Electronics Components Manufacturing Scheme mein outlay badhne se fayda hoga. Target: ₹920.
- Zensar Technologies: AI-driven solutions aur budget ke 'intelligence-first' approach se alignment.
Aage Kya?
Budget mein public capital expenditure ko ₹12.2 lakh crore tak badhaya gaya hai, jo infrastructure growth ke liye achha hai. AI, data centers, aur digital infrastructure par bhi focus hai. STT hike se trading volumes par thoda asar ho sakta hai, lekin long-term mein jo stocks budget ke capex aur tech agenda se judey hain, unke liye outlook positive lag raha hai.